@prefix jvr: <http://data.loterre.fr/ark:/67375/JVR> .
@prefix skos: <http://www.w3.org/2004/02/skos/core#> .
@prefix mesh: <http://id.nlm.nih.gov/mesh/vocab#> .
@prefix dc: <http://purl.org/dc/terms/> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .

jvr:-BT300B3G-Q
  skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-L6C0XPHT-4
  skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-XV06LPML-W
  skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-RLGZ62D2-Z
  skos:prefLabel "Antimétabolites antinéoplasiques"@fr, "Antimetabolites, Antineoplastic"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-Q3979798-W
  skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H7K65Q8S-Z
  skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-TJHVZCRZ-0
  skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-G30ZJ446-J
  skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NFTHND7Q-8
  skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-FWD2BGQ0-9
  skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-THHNVC7V-3
  skos:prefLabel "synthèse chimique (Qualificatif)"@fr, "chemical synthesis (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-R0ZCQ8X6-J
  skos:prefLabel "agonistes (Qualificatif)"@fr, "agonists (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-S0CS1X5R-5
  skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-M63HSDM7-1
  skos:prefLabel "antagonists & inhibitors (Qualifier)"@en, "antagonistes et inhibiteurs (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-HQRFT0C6-B
  skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-NB0XHT3S-N
  skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-W6SQV79N-S
  skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-CB30NGKB-3
  skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-H8LJ47P7-S
  skos:prefLabel "Immunosuppresseurs"@fr, "Immunosuppressive Agents"@en ;
  a mesh:Descriptor, skos:Concept .

jvr:-G4R176S9-J
  skos:prefLabel "analogs & derivatives (Qualifier)"@en, "analogues et dérivés (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr: a skos:ConceptScheme .
jvr:-SBNWSM1T-R
  skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-N86PNB5Q-Z
  skos:prefLabel "6-Méthylsulfanyl-9-bêta-D-ribofuranosyl-purine"@fr, "Methylthioinosine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:broader jvr:-ZWK33BZQ-0 .

jvr:-LPTSB5NL-T
  skos:prefLabel "Thionucléosides"@fr, "Thionucleosides"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-ZWK33BZQ-0 .

jvr:-ZWK33BZQ-0
  skos:altLabel "46S541971T"@fr, "46S541971T"@en, "Ribosyl-6-mercaptopurine"@en, "574-25-4 (Thioinosine)"@fr, "574-25-4 (Thioinosine)"@en, "6-Mercaptopurine Riboside"@en, "9-bêta-D-Ribofuranosyl-purine-6-thiol"@fr, "Inosine, 6-thio-"@fr, "Inosine, 6-thio-"@en, "9-bêta-D-Ribofuranosylpurine-6-thiol"@fr ;
  mesh:allowableQualifier jvr:-G30ZJ446-J, jvr:-NB0XHT3S-N, jvr:-M63HSDM7-1, jvr:-TJHVZCRZ-0, jvr:-G4R176S9-J, jvr:-SBNWSM1T-R, jvr:-W6SQV79N-S, jvr:-Q3979798-W, jvr:-R3QWLHRG-V, jvr:-NKM836P1-M, jvr:-BT300B3G-Q, jvr:-H7K65Q8S-Z, jvr:-R0ZCQ8X6-J, jvr:-L6C0XPHT-4, jvr:-T9HQD7ST-J, jvr:-XV06LPML-W, jvr:-WK5F724J-1, jvr:-S0CS1X5R-5, jvr:-CB30NGKB-3, jvr:-HQRFT0C6-B, jvr:-NFTHND7Q-8, jvr:-THHNVC7V-3, jvr:-D0F21513-5, jvr:-NHL3D2X0-S, jvr:-FWD2BGQ0-9 ;
  mesh:pharmacologicalAction jvr:-H8LJ47P7-S, jvr:-RLGZ62D2-Z ;
  skos:hiddenLabel "NSC-4911"@fr, "NSC-4911"@en, "NSC4911"@fr ;
  dc:modified "2016-06-01"^^xsd:date ;
  a mesh:Descriptor, skos:Concept ;
  dc:established "1991-01-01"^^xsd:date ;
  owl:sameAs <http://id.nlm.nih.gov/mesh/D013868> ;
  skos:broader jvr:-GH41MCRM-S, jvr:-LPTSB5NL-T ;
  skos:inScheme jvr: ;
  skos:definition "Sulfhydryl analog of INOSINE that inhibits nucleoside transport across erythrocyte plasma membranes, and has immunosuppressive properties. It has been used similarly to MERCAPTOPURINE in the treatment of leukemia. (From Martindale, The Extra Pharmacopoeia, 30th ed, p503)"@en ;
  dc:created "1974-11-19"^^xsd:date ;
  skos:prefLabel "Thioinosine"@en, "Thioinosine"@fr ;
  skos:narrower jvr:-N86PNB5Q-Z .

jvr:-D0F21513-5
  skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-R3QWLHRG-V
  skos:prefLabel "standards (Qualifier)"@en, "normes (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-NHL3D2X0-S
  skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-T9HQD7ST-J
  skos:prefLabel "ressources et distribution (Qualificatif)"@fr, "supply & distribution (Qualifier)"@en ;
  a mesh:Qualifier, skos:Concept .

jvr:-GH41MCRM-S
  skos:prefLabel "Inosine"@fr, "Inosine"@en ;
  a mesh:Descriptor, skos:Concept ;
  skos:narrower jvr:-ZWK33BZQ-0 .

jvr:-NKM836P1-M
  skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .

jvr:-WK5F724J-1
  skos:prefLabel "pharmacokinetics (Qualifier)"@en, "pharmacocinétique (Qualificatif)"@fr ;
  a mesh:Qualifier, skos:Concept .